Abdullah Turan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abdullah Turan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Hüseyin Koçakgöl
Department of Urology, University of Health Sciences, Erzurum City Hospital, Yakutiye, Turkey
3 shared publications - Abdullah Erdogan
Department of Urology, University of Health Sciences, Bursa City Hospital, Bursa, Türkiye
2 shared publications - Emre Şam
Department of Urology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey
2 shared publications - İbRahim Karabulut
Department of Urology, University of Health Sciences, Erzurum City Hospital, Erzurum 25240, Türkiye
2 shared publications - Mehmet Sefa Altay
Department of Urology, Health Sciences University, Erzurum Regional Training and Research Hospital, Erzurum 25240, Türkiye
2 shared publications - Muhittin Atar
Department of Urology, University of Health Sciences, Erzurum City Hospital, Yakutiye, Turkey
2 shared publications
Latest Publications
- 7 May 2026
- Published by Springer Nature in International Urology and Nephrology
Comparison of monoplanar, cross-table bull’s-eye, and a hybrid ultrasound-fluoroscopy technique for renal access in supine PCNL: a cognitive mapping approach
Percutaneous needle access is a critical step in percutaneous nephrolithotomy (PCNL). Supine PCNL, favored for its anesthetic and physiological benefits, can be performed using various puncture techniques. This study compared the efficacy and radiation safety of monoplanar, cross-table bull's-eye, and a combined ultrasound (US)-fluoroscopy-guided access technique for supine PCNL. Between January 2021 and March 2025, 130 patients undergoing supine PCNL were reviewed in three groups: monoplanar (Group A, n = 41), cross-table bull's-eye (Group B, n = 45), and combined US-fluoroscopy (Group C, n = 44). In Group C, pre-procedural US established a cognitive vectorial roadmap to determine needle trajectory and depth. Punctures were performed under 0° fluoroscopy, with on-demand refinements using 0-30° rotation and cephalad angulation for depth verification. Perioperative outcomes and radiation times were compared. Total operative time, stone-free (SF) rates, complications, blood transfusion rates, creatinine (Cr) change, hemoglobin (Hb) loss, nephrostomy and hospital stay did not differ significantly among groups (p > 0.05). However, mean fluoroscopy time for successful puncture was significantly lower in the combined US-fluoroscopy group (26.59 s) compared to monoplanar (42.82 s) and cross-table bull's-eye (40.62 s) techniques (p < 0.001). The combined US-fluoroscopy-guided technique is feasible for supine PCNL and significantly reduces radiation exposure. By integrating US-derived cognitive planning with on-demand fluoroscopic verification, this hybrid approach facilitates efficient needle puncture without compromising procedural precision or clinical success. It serves as a valuable alternative for optimizing radiation safety in urologic practice.
- 7 May 2026
- Published by Springer Nature in International Urology and Nephrology
Comparison of monoplanar, cross-table bull’s-eye, and a hybrid ultrasound-fluoroscopy technique for renal access in supine PCNL: a cognitive mapping approach
Percutaneous needle access is a critical step in percutaneous nephrolithotomy (PCNL). Supine PCNL, favored for its anesthetic and physiological benefits, can be performed using various puncture techniques. This study compared the efficacy and radiation safety of monoplanar, cross-table bull's-eye, and a combined ultrasound (US)-fluoroscopy-guided access technique for supine PCNL. Between January 2021 and March 2025, 130 patients undergoing supine PCNL were reviewed in three groups: monoplanar (Group A, n = 41), cross-table bull's-eye (Group B, n = 45), and combined US-fluoroscopy (Group C, n = 44). In Group C, pre-procedural US established a cognitive vectorial roadmap to determine needle trajectory and depth. Punctures were performed under 0° fluoroscopy, with on-demand refinements using 0-30° rotation and cephalad angulation for depth verification. Perioperative outcomes and radiation times were compared. Total operative time, stone-free (SF) rates, complications, blood transfusion rates, creatinine (Cr) change, hemoglobin (Hb) loss, nephrostomy and hospital stay did not differ significantly among groups (p > 0.05). However, mean fluoroscopy time for successful puncture was significantly lower in the combined US-fluoroscopy group (26.59 s) compared to monoplanar (42.82 s) and cross-table bull's-eye (40.62 s) techniques (p < 0.001). The combined US-fluoroscopy-guided technique is feasible for supine PCNL and significantly reduces radiation exposure. By integrating US-derived cognitive planning with on-demand fluoroscopic verification, this hybrid approach facilitates efficient needle puncture without compromising procedural precision or clinical success. It serves as a valuable alternative for optimizing radiation safety in urologic practice.
- 8 April 2026
- Published by Taylor & Francis in Journal of Sex & Marital Therapy
- Vol. 52 (4) , 455-465
Gum Chewing Therapy vs. Biofeedback for Lifelong Premature Ejaculation: A Prospective Randomized Comparative Study
There is no single, universally accepted definition of premature ejaculation (PE). Although various definitions exist, the International Society for Sexual Medicine (ISSM) defines PE as the persist...
- 8 April 2026
- Published by Taylor & Francis in Journal of Sex & Marital Therapy
- Vol. 52 (4) , 455-465
Gum Chewing Therapy vs. Biofeedback for Lifelong Premature Ejaculation: A Prospective Randomized Comparative Study
There is no single, universally accepted definition of premature ejaculation (PE). Although various definitions exist, the International Society for Sexual Medicine (ISSM) defines PE as the persist...
- Open Access
- 29 December 2025
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Factors predicting ureteral stenosis after transurethral resection of the ureteral orifice: a two-center, retrospective clinical study
We aimed to evaluate the factors predictive of ureteral stenosis after orifice resection and to determine whether ureteral stenting is effective in prevent
- 29 December 2025
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessFactors predicting ureteral stenosis after transurethral resection of the ureteral orifice: a two-center, retrospective clinical study
We aimed to evaluate the factors predictive of ureteral stenosis after orifice resection and to determine whether ureteral stenting is effective in prevent
- 13 May 2020
- Published by SAGE Publications in Urologia Journal
- Vol. 87 (4) , 209-213
Can we contribute to the diagnosis of diabetes and regulation of blood glucose by increasing the urologists’ awareness of glucosuria?
Aims: Diabetes mellitus is a progressive, chronic, systemic, metabolic disease that must be managed effectively. Its prevalence is increasing rapidly. We investigated whether urologists’ awareness and recognition of glucosuria contributed to the diagnosis of diabetes and regulation of blood glucose. Methods: A total of 39,053 patients were retrospectively evaluated between January 2018 and February 2019. Of them, 16,211 had undergone urinalysis for varied reasons. Glucosuria was semi-quantitatively measured as (+), (++), (+++), and (++++). Patients were assessed in terms of whether they had been referred to endocrinology or internal medicine departments within the 15 days and the presence/absence of a previous or new diagnosis of diabetes mellitus by measuring blood glucose and HgbA1c levels. Results: Glucosuria was detected in 665 patients (4.1%), of whom 495 were included in the study. 417 (84.2%) had been previously diagnosed with diabetes mellitus, and 56 (11.3%) newly received a diabetes mellitus diagnosis. Blood glucose and HbA1c values were normal in 22 (4.4%) patients with glucosuria. HgbA1c value was determined as 7 or above in 381 (91.3%) of 417 cases with a previous diabetes mellitus diagnosis. Conclusion: Referring all patients detected to have glucosuria in the spot urine test at any time regardless of fasting/non-fasting to the relevant departments can contribute to the diagnosis and treatment of diabetes mellitus disease.
- 13 May 2020
- Published by SAGE Publications in Urologia Journal
- Vol. 87 (4) , 209-213
Can we contribute to the diagnosis of diabetes and regulation of blood glucose by increasing the urologists’ awareness of glucosuria?
Aims: Diabetes mellitus is a progressive, chronic, systemic, metabolic disease that must be managed effectively. Its prevalence is increasing rapidly. We investigated whether urologists’ awareness and recognition of glucosuria contributed to the diagnosis of diabetes and regulation of blood glucose. Methods: A total of 39,053 patients were retrospectively evaluated between January 2018 and February 2019. Of them, 16,211 had undergone urinalysis for varied reasons. Glucosuria was semi-quantitatively measured as (+), (++), (+++), and (++++). Patients were assessed in terms of whether they had been referred to endocrinology or internal medicine departments within the 15 days and the presence/absence of a previous or new diagnosis of diabetes mellitus by measuring blood glucose and HgbA1c levels. Results: Glucosuria was detected in 665 patients (4.1%), of whom 495 were included in the study. 417 (84.2%) had been previously diagnosed with diabetes mellitus, and 56 (11.3%) newly received a diabetes mellitus diagnosis. Blood glucose and HbA1c values were normal in 22 (4.4%) patients with glucosuria. HgbA1c value was determined as 7 or above in 381 (91.3%) of 417 cases with a previous diabetes mellitus diagnosis. Conclusion: Referring all patients detected to have glucosuria in the spot urine test at any time regardless of fasting/non-fasting to the relevant departments can contribute to the diagnosis and treatment of diabetes mellitus disease.
- 12 March 2019
- Published by Taylor & Francis in The Aging Male
- Vol. 23 (1) , 59-65
Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL?
Objective: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the most common benign and malignant diseases of the prostate gland. The clinical distinction between BPH and PCa should be determined to guide patients to appropriate treatment. We aimed to evaluate the value of PSA, prostate volume (PV) and associated parameters for the detection of PCa in patients with PSA levels of 2.5–30.0 ng/mL. Materials and methods: A total of 211 men with a biopsy (≥10 cores) and a PSA of 2.5–30.0 ng/ml were included in the study. To evaluate the performance of PV in diagnosing PCa, subjects were divided into PSA 2.5–10.0 ng/ml and PSA 10.1–30.0 ng/ml groups. Age, BMI, PSA, PV, f/t PSA, PSAD, and biopsy Gleason score were included in the analysis. Results: PCa was diagnosed in 74 (35.1%) of the 211 patients. The differences in f/t PSA, PV, and PSAD for patients with and without PCa were statistically significant. (p < .001). PV was a significantly better indicator of PCa than PSAD and f/t PSA ratio in both groups. Conclusions: PV plays an active role in predicting PCa in patients with PSA in gray-zone as well as in patients with PSA 10.1–30 ng/mL.
- 12 March 2019
- Published by Taylor & Francis in The Aging Male
- Vol. 23 (1) , 59-65
Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL?
Objective: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the most common benign and malignant diseases of the prostate gland. The clinical distinction between BPH and PCa should be determined to guide patients to appropriate treatment. We aimed to evaluate the value of PSA, prostate volume (PV) and associated parameters for the detection of PCa in patients with PSA levels of 2.5–30.0 ng/mL. Materials and methods: A total of 211 men with a biopsy (≥10 cores) and a PSA of 2.5–30.0 ng/ml were included in the study. To evaluate the performance of PV in diagnosing PCa, subjects were divided into PSA 2.5–10.0 ng/ml and PSA 10.1–30.0 ng/ml groups. Age, BMI, PSA, PV, f/t PSA, PSAD, and biopsy Gleason score were included in the analysis. Results: PCa was diagnosed in 74 (35.1%) of the 211 patients. The differences in f/t PSA, PV, and PSAD for patients with and without PCa were statistically significant. (p < .001). PV was a significantly better indicator of PCa than PSAD and f/t PSA ratio in both groups. Conclusions: PV plays an active role in predicting PCa in patients with PSA in gray-zone as well as in patients with PSA 10.1–30 ng/mL.